Although there is no conclusive evidence linking germline BRIP1 mutations to an elevated risk of breast cancer, these mutations are significantly correlated with an absolute lifetime risk of up to 15% for ovarian cancer. This evidence concerns the gene BRIP1 and ovarian carcinoma.